Patents by Inventor Jack N. Losso

Jack N. Losso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11224612
    Abstract: Glycosaminoglycans, particularly hyaluronic acid, are extracted from alligator carcasses, feet, backstraps, and eyeballs. The alligator-derived glycosaminoglycans can be used in treatments for cystic fibrosis (CF), in treating other inflammatory conditions, and for other purposes.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: January 18, 2022
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechnical College
    Inventors: Jack N. Losso, Jose Daniel Estrada Andino
  • Patent number: 10568939
    Abstract: An intervention for sleep disorders comprises collagen, a gelatin peptide, or the amino acid glycine; L-theanine; lactucopicrin, deoxylactucopicrin, or another lactucopicrin derivative; hyaluronic acid; epigallocatechin gallate; and quinic acid. The intervention helps regulate pro-inflammatory biomarkers that are often associated with insomnia development and progression. These biomarkers include cytokines and enzymes associated with tryptophan degradation. Inhibition of these enzymes and cytokines improves tryptophan availability and sleep quality, and allows individuals to sleep better with fewer side effects. The novel composition promotes high-quality, deep sleep.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: February 25, 2020
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Jack N. Losso, Jose Daniel Estrada Andino
  • Publication number: 20190321450
    Abstract: An intervention for sleep disorders comprises collagen, a gelatin peptide, or the amino acid glycine; L-theanine; lactucopicrin, deoxylactucopicrin, or another lactucopicrin derivative; hyaluronic acid; epigallocatechin gallate; and quinic acid. The intervention helps regulate pro-inflammatory biomarkers that are often associated with insomnia development and progression. These biomarkers include cytokines and enzymes associated with tryptophan degradation. Inhibition of these enzymes and cytokines improves tryptophan availability and sleep quality, and allows individuals to sleep better with fewer side effects. The novel composition promotes high-quality, deep sleep.
    Type: Application
    Filed: July 3, 2019
    Publication date: October 24, 2019
    Applicant: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Jack N. Losso, Jose Daniel Estrada Andino
  • Patent number: 10376566
    Abstract: An intervention for sleep disorders comprises: collagen, a gelatin peptide, or the amino acid glycine; L-theanine; lactucopicrin, deoxylactucopicrin, or another lactucopicrin derivative; hyaluronic acid; epigallocatechin gallate; and quinic acid. The intervention helps regulate pro-inflammatory biomarkers that are often associated with insomnia development and progression. These biomarkers include cytokines and enzymes associated with tryptophan degradation. Inhibition of these enzymes and cytokines improves tryptophan availability and sleep quality, and allows individuals to sleep better with fewer side effects. The composition promotes high-quality, deep sleep.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: August 13, 2019
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Jack N. Losso, Jose Daniel Estrada Andino
  • Publication number: 20180021411
    Abstract: An intervention for sleep disorders comprises: collagen, a gelatin peptide, or the amino acid glycine; L-theanine; lactucopicrin, deoxylactucopicrin, or another lactucopicrin derivative; hyaluronic acid; epigallocatechin gallate; and quinic acid. The intervention helps regulate pro-inflammatory biomarkers that are often associated with insomnia development and progression. These biomarkers include cytokines and enzymes associated with tryptophan degradation. Inhibition of these enzymes and cytokines improves tryptophan availability and sleep quality, and allows individuals to sleep better with fewer side effects. The composition promotes high-quality, deep sleep.
    Type: Application
    Filed: June 16, 2017
    Publication date: January 25, 2018
    Applicant: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Jack N. Losso, Jose Daniel Estrada Andino
  • Publication number: 20100266665
    Abstract: A process for obtaining fenugreek flour from fenugreek seeds has been developed, and the flour incorporated into baked or other food products. The processed fenugreek flour from boiled seeds was easier to add into food products than whole seeds and did not compromise the food's taste or texture. This fenugreek flour can be included in everyday food items and will allow increased use in fenugreek to aid in the prevention of diabetes and obesity. Using this flour, a fenugreek bread formula was developed, and the bread was produced in a commercial bakery by incorporating fenugreek flour into a standard wheat bread formula. Eight diet controlled diabetic subjects were served wheat bread with about 5% fenugreek, and the consumption of the fenugreek bread was shown to reduce serum insulin indicating the bioactivity of the fenugreek remained in the bread.
    Type: Application
    Filed: April 19, 2010
    Publication date: October 21, 2010
    Inventors: Jack N. Losso, John W. Finley, Darryl L. Holliday, Luke A. Mumphrey
  • Patent number: 7671242
    Abstract: An efficient method is disclosed for extracting lutein from corn, sweet potato, and other plant products, and for extracting aflatoxin-free lutein from aflatoxin-contaminated plant grains and other plant products safely without any toxic by-products. The lutein is extracted using acetone, and either chilled or saponified to separate from the lipids. If contaminated with aflatoxin, the extracted aflatoxin-contaminated lutein is treated with lipoxidase. This method may be used in producing aflatoxin-free lutein from other contaminated grains or plant oils, or other plant products, including corn, cotton, soybean, rice, barley, wheat, maize, millet, and peanut.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: March 2, 2010
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Jack N. Losso, Evdokia Menelaou, Joan M. King
  • Patent number: 7109300
    Abstract: A method is disclosed for extracting collagen from calcified tissue without a prior decalcification step. The method may be used with calcified tissues such as fish skin with scales, alligator skeletons, and crustacean exoskeletons. It does not require the use of EDTA. When fish skin is used that contains substantial quantities of scales, it is not necessary first to remove scales from the skin before conducting the extraction of collagen.
    Type: Grant
    Filed: April 18, 2005
    Date of Patent: September 19, 2006
    Assignee: Board of Supervisors of Louisiana State Univeristy And Agricultural and Mechanical College
    Inventors: Jack N. Losso, Masahiro Ogawa, Ralph J. Portier, Mark A. Schexnayder